Flexeril and Calcium gluconate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Calcium gluconate (calcium). Common drug interactions include cough among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Flexeril and Calcium gluconate. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.

What is Calcium gluconate?

Calcium gluconate has active ingredients of calcium. eHealthMe is studying from 6,181 Calcium gluconate users. Check the latest studies of Calcium gluconate.



On Jul, 19, 2026

24 people who take Flexeril and Calcium gluconate together, and have interactions are studied.

Flexeril and Calcium gluconate drug interactions.

What are the common drug interactions of Flexeril and Calcium Gluconate, by gender? *:

female:

  1. Cough
  2. General physical health deterioration (weak health status)
  3. Hypertension (high blood pressure)
  4. Left ventricular dysfunction
  5. Lung disorder (lung disease)
  6. Mitral valve calcification (calcium deposit in mitral valve)
  7. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  8. Retinal vascular occlusion (a blockage of the small veins that carry blood away from the retina)
  9. Sensation of foreign body
  10. Sensation of heaviness

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Pneumonia
  3. Blood bicarbonate decreased
  4. Blood creatinine increased
  5. Blood magnesium decreased
  6. Blood pressure increased
  7. Colitis (inflammation of colon)
  8. Dehydration (dryness resulting from the removal of water)
  9. Drug ineffective
  10. Dry skin

What are the common drug interactions of Flexeril and Calcium Gluconate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Post procedural complication
  2. Procedural pain
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Retinal vascular occlusion (a blockage of the small veins that carry blood away from the retina)
  5. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  6. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  7. Abdominal pain
  8. Acute respiratory distress syndrome
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Anaemia (lack of blood)

50-59:

  1. Asthma
  2. Colitis (inflammation of colon)
  3. Cough
  4. Dyspnoea (difficult or laboured respiration)
  5. Lung disorder (lung disease)
  6. Platelet count decreased
  7. Sensation of foreign body
  8. Sensation of heaviness
  9. Sensation of pressure

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Vomiting
  3. Cardiogenic shock (inadequate circulation of blood)
  4. Chest pain
  5. Cholecystitis acute (rapid infection of gallbladder)
  6. Congestive cardiomyopathy (weakening of heart muscle)
  7. Decreased appetite
  8. Fatigue (feeling of tiredness)
  9. General physical health deterioration (weak health status)
  10. Hyperbilirubinaemia (excess of bilirubin in the blood)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 10 people, 41.67%
  2. Multiple Myeloma (cancer of the plasma cells): 10 people, 41.67%
  3. Pain: 9 people, 37.50%
  4. High Blood Pressure: 8 people, 33.33%
  5. Insomnia (sleeplessness): 6 people, 25.00%
  6. Osteoporosis (bones weak and more likely to break): 5 people, 20.83%
  7. Oedema (fluid collection in tissue): 5 people, 20.83%
  8. Infection: 5 people, 20.83%
  9. Indigestion: 5 people, 20.83%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 20.83%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Calcium gluconate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flexeril and Calcium gluconate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Calcium gluconate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium gluconate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and calcium (the active ingredients of Flexeril and Calcium gluconate, respectively), and Flexeril and Calcium gluconate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: